C4 Therapeutics (CCCC) Other financing activities (2020 - 2026)
C4 Therapeutics' (CCCC) quarterly Other financing activities came in at $605000.0 in Q1 2026, up 455.05% year-on-year from $109000.0 in Q1 2025, and up 465.42% quarter-over-quarter from $107000.0 in Q3 2025.
C4 Therapeutics (CCCC) Other financing activities (2020 - 2026) Analysis & Trends
C4 Therapeutics' Other financing activities history runs 7 years deep, the most recent figure standing at $605000.0 for Q1 2026.
- On a quarterly basis, Other financing activities rose 455.05% year-over-year to $605000.0 in Q1 2026; TTM through Mar 2026 was $603000.0, a 48.16% increase from a year earlier, with the FY2025 full-year figure at $107000.0, down 71.99% from the prior year.
- Other financing activities grew to $605000.0 in Q1 2026 per CCCC's latest filing, from $107000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $605000.0 in Q1 2026 and bottomed at -$360000.0 in Q4 2022.
- The 5-year median for Other financing activities is $104000.0 (2023), against an average of $117076.9.
- Biggest YoY gain for Other financing activities was 8766.67% in 2022; the steepest drop was 105.65% in 2022.
- Year by year, Other financing activities stood at -$360000.0 in 2022, then jumped by 87.22% to -$46000.0 in 2023, then soared by 102.17% to $1000.0 in 2024, then jumped by 10600.0% to $107000.0 in 2025, then surged by 465.42% to $605000.0 in 2026.
- Per Business Quant, the three latest CCCC Other financing activities figures stand at $605000.0 (Q1 2026), $107000.0 (Q3 2025), and -$109000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | C4 Therapeutics | 460.17 Mn | 224.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 605,000.00 |
| Mar 31, 2026 | 605,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | -109,000.00 |
| Jun 30, 2025 | -109,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 297,000.00 |
| Sep 30, 2024 | 297,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Jun 30, 2023 | -46,000.00 |
| Jun 30, 2023 | -46,000.00 |
| Mar 31, 2023 | 104,000.00 |
| Mar 31, 2023 | 104,000.00 |
| Dec 31, 2022 | -360,000.00 |
| Dec 31, 2022 | -360,000.00 |